Missing the consensus estimates for both EPS and sales is likely to have a negative short-term impact on Novartis' stock price. However, the year-over-year growth in earnings and sales may provide some cushion to the negative sentiment. The score reflects the immediate negative reaction typically seen in the market to earnings misses, while the importance is high due to the significance of earnings reports in evaluating company performance. The confidence level is not at the maximum because the market may also consider the year-over-year growth positively, which could mitigate the impact.